Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Minji Seo
Institution:
University of Hawaii Cancer Center
Observed institution:
University of Hawaii Cancer Center
ORCID:
0009-0008-7457-7722
Observed ORCID:
0009-0008-7457-7722
OpenAlex ID:
A5138795125
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
·
Clinical Cancer Research
·
30
PDF
Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer
2026
·
Minji Seo
, Jangsoon Lee
, et al.
·
Advanced Science
·
7
CD44v9 as a therapeutic target for antibody-drug conjugate in advanced breast cancer
2026
·
Dileep R. Reddy
, McKenna E. Flynn
, et al.
·
Biomedicine & Pharmacotherapy
·
2
Data from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
·
1
Abstract A013: Preclinical Development of a Humanized CD44v9-Directed Antibody-Drug Conjugate for Treatment-Refractory Breast Cancer
2026
·
Naoto T. Ueno
, Dileep R. Reddy
, et al.
·
Clinical Cancer Research
Supplementary Table 3 from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
Supplementary Table 1 from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
Supplementary Figures 1-8 from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
Supplementary Table 4 from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
Supplementary Table 2 from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
Supplementary Table 5 from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
2026
·
Dileep Reddy Rampa
, Minji Seo
, et al.
Abstract LB171: AI-based B2SC identifies pre-existing TOP2A/E2F-active populations driving resistance to T-DXd in HER2+ breast cancer
2026
·
Se-eun Han
, Minwoo Jung
, et al.
·
Cancer Research
Abstract 2659: CD44v9-targeted antibody-drug conjugate as a novel therapy for advanced breast cancer
2026
·
Dileep R. Reddy
, McKenna E. Flynn
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
40
H-index:
2
I10-index:
1
Year
Topic
Type